| RS10111612 |
TACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1011184132 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1011185031 |
PEX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5B |
| RS1011193191 |
EYS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1011196447 |
GFPT1
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 12, Abnormality of the musculature |
| RS1011200048 |
BSCL2
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Congenital generalized lipodystrophy type 2 |
| RS1011204533 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1011254015 |
BCL11B
|
Health Risk |
Conflicting classifications of pathogenicity |
BCL11B-related disorder, BCL11B-related disorder |
| RS1011282445 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS1011286644 |
AMPD2
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 9, Pontocerebellar hypoplasia type 9 |
| RS1011303295 |
WNT10A
|
Health Risk |
Pathogenic/Likely pathogenic |
Odonto-onycho-dermal dysplasia, Schöpf-Schulz-Passarge syndrome |
| RS1011307501 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, T-B+ severe combined immunodeficiency due to JAK3 deficiency |
| RS1011357372 |
NFIB
|
Health Risk |
Likely pathogenic |
Macrocephaly, acquired |
| RS1011397929 |
SGCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS1011425121 |
NEB
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS1011427406 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1011427549 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS10114470 |
TNFSF15
|
Health Risk |
Uncertain risk allele |
Leprosy, susceptibility to |
| RS1011453043 |
ADAMTS18
|
Health Risk |
Pathogenic |
Microcornea-myopic chorioretinal atrophy, Microcornea-myopic chorioretinal atrophy |
| RS1011460663 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiac arrhythmia |
| RS1011464295 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 2, Aortic valve disease 2 |
| RS1011464708 |
SUCLA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS1011480433 |
IL1RN
|
Health Risk |
Likely pathogenic |
IL1RN-related disorder, IL1RN-related disorder |
| RS1011484252 |
LRP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cenani-Lenz syndactyly syndrome, Congenital myasthenic syndrome 17 |
| RS1011541536 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 29 |
| RS1011558573 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1011559873 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS1011581295 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS1011589357 |
DDRGK1
|
Health Risk |
Pathogenic |
Spondyloepimetaphyseal dysplasia, Shohat type |
| RS1011619050 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolman disease, Cardiovascular phenotype |
| RS1011631903 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS1011669605 |
NPC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C2 |
| RS1011669872 |
HSPB8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS10117 |
HSPA9
|
Health Risk |
Conflicting classifications of pathogenicity |
Even-plus syndrome, Even-plus syndrome |
| RS1011715171 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS1011716245 |
RARS2
|
Health Risk |
Likely pathogenic |
— |
| RS1011727375 |
GHR
|
Health Risk |
Pathogenic/Likely pathogenic |
Laron-type isolated somatotropin defect, Growth hormone insensitivity syndrome |
| RS1011754140 |
CDK8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with hypotonia and behavioral abnormalities, Intellectual developmental disorder with hypotonia and behavioral abnormalities |
| RS1011757302 |
TPRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS1011767398 |
SP110
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatic veno-occlusive disease-immunodeficiency syndrome, Mycobacterium tuberculosis |
| RS1011767739 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS1011775158 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Ehlers-Danlos syndrome |
| RS1011857582 |
PIKFYVE
|
Health Risk |
Pathogenic |
PIKFYVE-related disorder, PIKFYVE-related disorder |
| RS1011870043 |
FANCM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS1011923461 |
IFT172
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS1011931149 |
SEC63
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic liver disease, Autosomal dominant polycystic liver disease |
| RS1011934257 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
8 conditions, 8 conditions |
| RS1011978513 |
PCCB
|
Health Risk |
Conflicting classifications of pathogenicity |
Propionic acidemia, PCCB-related disorder |
| RS1011986078 |
NPHP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, Nephronophthisis |
| RS1011987148 |
GBA2
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1012004126 |
ACAD9
|
Health Risk |
Likely pathogenic |
Acyl-CoA dehydrogenase 9 deficiency, Mitochondrial complex I deficiency |
| RS1012017728 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Stargardt disease, Retinal dystrophy |
| RS1012068196 |
SCN5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 3, Brugada syndrome 1 |
| RS1012084121 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrin deficiency, Citrullinemia |
| RS1012101301 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, EP300-related disorder |
| RS1012160082 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1012166328 |
FBXO7
|
Health Risk |
Conflicting classifications of pathogenicity |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS1012168637 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bilateral frontoparietal polymicrogyria, Inborn genetic diseases |
| RS1012171328 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Merosin deficient congenital muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1012178126 |
AMH
|
Health Risk |
Likely pathogenic |
— |
| RS1012193526 |
MCCC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylcrotonyl-CoA carboxylase deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS1012219606 |
CHD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS1012221437 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS1012247750 |
JUP
|
Health Risk |
Conflicting classifications of pathogenicity |
Naxos disease, Arrhythmogenic right ventricular dysplasia 12 |
| RS1012254852 |
UPB1
|
Health Risk |
Likely pathogenic |
Deficiency of beta-ureidopropionase, UPB1-related disorder |
| RS1012275384 |
TSEN54
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 4, Pontocerebellar hypoplasia type 2A |
| RS1012284944 |
ABCA4
|
Health Risk |
Likely pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1012350596 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1012398135 |
COL7A1
|
Health Risk |
Pathogenic |
Epidermolysis bullosa dystrophica, Epidermolysis bullosa dystrophica |
| RS1012399660 |
MAPKAPK5
|
Health Risk |
Pathogenic |
Neurocardiofaciodigital syndrome, Neurocardiofaciodigital syndrome |
| RS1012418859 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1012449574 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS1012455878 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS1012468951 |
DNHD1
|
Health Risk |
Pathogenic |
— |
| RS1012472070 |
PIEZO1
|
Health Risk |
Likely pathogenic |
— |
| RS1012493577 |
NR2E3
|
Health Risk |
Conflicting classifications of pathogenicity |
Enhanced S-cone syndrome, Enhanced S-cone syndrome |
| RS1012514808 |
SYNE1
|
Health Risk |
Likely pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1012567148 |
COL6A2
|
Health Risk |
Likely pathogenic |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS1012575668 |
ABCB4
|
Health Risk |
Pathogenic/Likely pathogenic |
Low phospholipid associated cholelithiasis, Cholestasis |
| RS1012634268 |
ALPK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1012665311 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1012702109 |
IGHMBP2
|
Health Risk |
Likely pathogenic |
Autosomal recessive distal spinal muscular atrophy 1, Charcot-Marie-Tooth disease axonal type 2S |
| RS1012740056 |
FOLR1
|
Health Risk |
Likely pathogenic |
— |
| RS1012750146 |
NKX2-5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Atrial septal defect 7 |
| RS1012756707 |
AAAS
|
Health Risk |
Pathogenic |
— |
| RS1012765041 |
PDE6C
|
Health Risk |
Pathogenic |
— |
| RS1012778505 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS1012809189 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS1012819766 |
KIF5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 10 |
| RS1012901050 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS1012929202 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1012938610 |
IFNGR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 28, IFNGR2-related disorder |
| RS1012962799 |
HUWE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1013015106 |
SGCB
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy |
| RS1013032001 |
EIF2AK3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1013039657 |
AHDC1
|
Health Risk |
Likely pathogenic |
— |
| RS1013053543 |
CYP4V2
|
Health Risk |
Pathogenic |
— |
| RS1013079991 |
BSCL2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 2, Berardinelli-Seip congenital lipodystrophy |
| RS1013100046 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1013131972 |
MYO5B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital microvillous atrophy, Congenital microvillous atrophy |